Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kwangdong Pharm is a prominent South Korean pharmaceutical company that bridges the gap between traditional herbal medicine and modern Western pharmaceuticals. Founded in 1963, the company has grown into a diversified healthcare leader, widely recognized for its successful consumer health beverage line, including Vita 500 and Corn Silk Tea. Beyond consumer goods, Kwangdong operates a sophisticated pharmaceutical business with a focus on oncology, women's health, and rare diseases, often acting as a key strategic partner for global pharmaceutical firms entering the Korean market. The company's R&D efforts are currently centered on metabolic diseases and specialized therapeutics, such as treatments for female sexual dysfunction. Kwangdong maintains a strong distribution network and manufacturing facilities that adhere to international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kwangdong Pharm.